Due to drug shortages, which might occur with a possibility of no-deal Brexit, a list of 24 medicines has been published by the UK’s Medicines that cannot be parallel exported from the UK.

The list includes drugs like the antiviral oseltamivir, adrenaline, the blood thinner rivaroxaban, hormone therapies estradiol and levonorgestrel, and the high blood pressure medicine prazosin, among others. The reason why the UK has decided to restrict these medicines from parallel export is that the practice can create or worsen supply shortages